title: [Certification of breast centers].
abstract: The primary focus of the establishment and certification of specialized cancer centers in the context of the National Cancer Plan is to improve the quality of care for patients with various carcinoma entities. The era of organ center certification started with the establishment of specialized breast cancer centers in line with the high incidence of breast cancer, the high mortality rate and the high level of interdisciplinary cooperation in the diagnosis and therapy of breast cancer. The introduction of quality management and external monitoring aims to provide high quality care in the diagnosis and therapy of breast cancer and is expected to improve long-term quality data (disease-free survival and overall survival) and to reduce mortality rates by about 25-30%. Certification requires the implementation of a quality management system and care provision structures assuring diagnosis and therapy according to the quality guidelines and recommendations of the specialist societies. Basic requirements for improving the quality of breast cancer patient care are centralization, specialization and interdisciplinarity. It has been demonstrated that the improvement of overall survival is associated with an increasing annual case load of a center, an increasing case load per surgeon per year, study participation and interdisciplinarity. Tumor documentation will be harmonized in the future by the establishment of local clinical cancer registries and cross-linking them with the National Cancer Registry. The data collection and analysis of several quality markers and current follow-up and survival data for each breast cancer patient will allow direct comparison of participating institutions. Individual breast cancer centers may demonstrate quality improvement longitudinally. Both certification and specialization require additional services which are associated with a substantial increase in costs. Preliminary data suggest that certified breast cancer centers are dependent on cross-financing by the participating departments of a hospital. Up to now cost-effective analyses for certified breast cancer centers are not available due to a substantial lack of data defining the additional financial burden.
authors.affiliation: Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität, Campus Grosshadern, Marchioninistr. 15, 81377, München, Deutschland. karin.hellerhoff@med.uni-muenchen.de
authors.forename: K
authors.initials: K
authors.lastname: Hellerhoff
mesh_terms: D019985:Benchmarking / Q000191:economics / Q000592:standards; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002173:Cancer Care Facilities / Q000191:economics / Q000592:standards*; D002568:Certification / Q000191:economics / Q000592:standards*; D003362:Cost-Benefit Analysis / Q000592:standards; D005260:Female; D005858:Germany; D006801:Humans; D008006:Licensure, Hospital / Q000191:economics / Q000592:standards*; D017063:Outcome Assessment, Health Care / Q000191:economics / Q000592:standards